Neoplasia/BPH

	Elevated C-reactive protein to albumin ratio is a promising predictive biomarker for prognosis in patients with renal cell carcinoma. Ann Med Xu C, Guo Y, Chen X, Liu X, Wu F, Lin S. PMID: 41566198 [PubMed - indexed for MEDLINE]
	De novo urothelial carcinoma in kidney transplant recipients: a single-center retrospective cohort study. Int Urol Nephrol Schmidt J, Lehnert M, Lichy I, Goranova I, Weinberger S, Jeutner J, Kurz L, Plage H, Schlomm T, Friedersdorff F, Peters R, Biernath N, Ralla B. PMID: 41566119 [PubMed - as supplied by publisher]
	Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center. J Robot Surg Zhang Y, Xu P, Wen Y, Xu Y, Xu K, Li B, Zou J, Du W, Wang Y, Liu Y, Liang T, Xu A, Chen B. PMID: 41565874 [PubMed - indexed for MEDLINE]
	Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial. Eur Urol Oncol Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C, Achard V, Stellamans K, Goetghebeur E, Reynders D, Ost P. PMID: 41565552 [PubMed - as supplied by publisher]
	Automated Classification of Adverse Events After Hydrogel Perirectal Spacer Insertion for Prostate Cancer Using Large Language Models. Urology Sohoni N, Sohoni NS, Sutherland RA, Sundaresan VM, Smani S, Ananth P, Onofrey JA, Aneja S, Miszczyk M, Lee HJ, Olivieri JE, Leapman MS. PMID: 41565161 [PubMed - as supplied by publisher]
	Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study. Sci Rep Langsenlehner T, Paal K, Thurner EM, Genser S, Sternat R, Stranz B, Renner W. PMID: 41565875 [PubMed - as supplied by publisher]
	European Study of Prostate Cancer Screening - 23-Year Follow-up. Reply. N Engl J Med Roobol MJ, de Vos II, Auvinen A. PMID: 41564408 [PubMed - in process]
	European Study of Prostate Cancer Screening - 23-Year Follow-up. N Engl J Med Thompson IM Jr. PMID: 41564407 [PubMed - in process]
	European Study of Prostate Cancer Screening - 23-Year Follow-up. N Engl J Med Raghavan D, Tannock IF. PMID: 41564406 [PubMed - in process]
	CT prostate angiogram for nerve-sparing robot-assisted radical prostatectomy. J Robot Surg Shanbhag A, Reisoglu S, Sabharwal T, Noël J. PMID: 41563651 [PubMed - indexed for MEDLINE]
	Retraction Note: Comment on: "Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study". World J Urol Aphale P, Dokania S, Shekhar H. PMID: 41563509 [PubMed - in process]
	A 24-Year Analysis of Percutaneous Renal Biopsy Trends in Australia. Med Sci (Basel) Sandhu K, Al-Khanaty A, Carll J, Murphy DG, Lawrentschuk N, Perera M. PMID: 41562909 [PubMed - indexed for MEDLINE]
	Fat quality, not quantity, linked to reduced risk of advanced and lethal prostate cancer in US populations: a large prospective multicenter study. Eur J Cancer Prev Li Y, Zhou M, Liao Y, Zhai Q, Zhang K, Huang X, Luo M, Lv S, Wei Q. PMID: 41562707 [PubMed - as supplied by publisher]
	Comment on "The role of adjuvant chemotherapy after radical surgery in patients with lymph node-positive bladder cancer or locally advanced (pT3, pT4a) bladder cancer: a meta-analysis and systematic review". Int J Surg Song S MSc, Yang W MSc, Gao C MD. PMID: 41562652 [PubMed - as supplied by publisher]
	Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study. Int J Urol Tanaka R, Shinohara M, Kawashima Y, Sekine Y, Narita S, Kobayashi S, Abe N, Kodama H, Fujita N, Okamoto T, Yamamoto H, Numakura K, Sato S, Habuchi T, Ohyama C, Hatakeyama S. PMID: 41562433 [PubMed - indexed for MEDLINE]
	Identification of prognostic biomarkers and development of a prediction model for prostate cancer. Front Immunol Chen D, Chen W, Ye R, Li L, Miao F, Kong X, Ning W, Jia J, Chen Q, Wang P, Yin B. PMID: 41562091 [PubMed - indexed for MEDLINE]
	Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. Front Immunol Hao L, Chen X, He T, Wu T, Wen Z, Ji Z, Zheng X, Zheng Q, Zhou Q, He C, Long Q, Sun D. PMID: 41562071 [PubMed - indexed for MEDLINE]
	Preoperative intravesical mitomycin C to reduce bladder recurrence in upper tract urothelial carcinoma - Insights from the landmark REBACARE trial. Indian J Urol Jain MP. PMID: 41562013 [PubMed]
	Toward a PSMA PET-mpMRI pathway for biopsy decision-making in men with suspected prostate cancer: interim results from the prospective BIOPSTAGE trial. Front Oncol Celli M, Gunelli R, Ferroni F, Costantini M, Barone D, Fantini L, Fragalà E, Marini I, Di Iorio V, Foca F, Monti M, Matteucci F, Caroli P. PMID: 41561764 [PubMed]
	Association between the red cell distribution width-to-albumin ratio and recurrence-free survival and overall survival in patients with non-muscle-invasive bladder cancer: a retrospective cohort study. Front Oncol Song F, Su S, Zhang X, Cao Y, Cui X, Zhang L, Li C, Li S. PMID: 41561745 [PubMed]

Articles 1 - 20 / 184826

Page 1 of 9242



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy